2017
DOI: 10.1080/09513590.2017.1399699
|View full text |Cite
|
Sign up to set email alerts
|

Improvement in quality of oocytes in polycystic ovarian syndrome in programs of in vitro fertilization

Abstract: Inositol therapy is aimed at improving the quality of oocytes during preconception care in patients with polycystic ovarian syndrome (PCOS), a cause of infertility and reproductive dysfunction. The objectives of this observational comparative multicentre study were to evaluate the effectiveness of inositol in improving the quality of oocytes/embryos and IVF cycle outcome. Group 1 patients (N ¼ 133) received inositol 1000 mg (Inofert or Nutrilinea) þ folic acid 0.1 mg. Group 2 consisted of patients with preserv… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(7 citation statements)
references
References 12 publications
(13 reference statements)
0
7
0
Order By: Relevance
“…Further demonstrations of myo-Ins efficacy came from two other studies: the first is an IVF clinical trial on 133 PCOS women [135], in which the authors reported that supplementation with 1 g myo-Ins and 400 µg folic acid significantly augmented the number of mature oocytes compared to the control group, treated with folic acid and cyanocobalamin. In the second prospective, controlled, randomized trial by Özay and colleagues, the clinicians provided a supplement of 4 g myo-Ins and 400 µg folic acid to 98 infertile PCOS patients undergoing controlled ovarian hyperstimulation with rFSH and intrauterine insemination [136].…”
Section: Myo-inositol Support To Assisted Reproduction Techniques (Art)mentioning
confidence: 99%
“…Further demonstrations of myo-Ins efficacy came from two other studies: the first is an IVF clinical trial on 133 PCOS women [135], in which the authors reported that supplementation with 1 g myo-Ins and 400 µg folic acid significantly augmented the number of mature oocytes compared to the control group, treated with folic acid and cyanocobalamin. In the second prospective, controlled, randomized trial by Özay and colleagues, the clinicians provided a supplement of 4 g myo-Ins and 400 µg folic acid to 98 infertile PCOS patients undergoing controlled ovarian hyperstimulation with rFSH and intrauterine insemination [136].…”
Section: Myo-inositol Support To Assisted Reproduction Techniques (Art)mentioning
confidence: 99%
“…A wealth of information regarding the importance of myo-ins in the ovaries comes from studies in pathological scenarios that lead to the need for assisted fertilization protocols. In particular, evidence derives from studies on patients with PCOS, the most common endocrinological syndrome in women of reproductive age, which leads to lower quality and maturity of oocytes and to consequently lower quality of embryos [40]. PCOS is often characterized by alterations of the inositol profile, both at ovarian and at global levels [41].…”
Section: Improvement Of the Ovulation Quality-oogenesismentioning
confidence: 99%
“…Nevertheless, these oocytes are often of low quality, leading to low fertilization, cleavage, and implantation. In most cases, treatment with some drugs overcomes anovulation associated with PCOS, leading to reductions in risk factors, and improves the response to ovulation induction [ 8 ]. Antioxidant supplements have been shown to improve insulin sensitivity and other health-threatening conditions in women with PCOS.…”
Section: Introductionmentioning
confidence: 99%
“…Antioxidant supplements have been shown to improve insulin sensitivity and other health-threatening conditions in women with PCOS. Despite the important role of alternative medicine, especially antioxidants, in the management of PCOS in women [ 8 ], there are not many well-designed studies reported in the literature, especially in Iran. On the other hand, existing studies on the use of antioxidants in PCOS women have yielded controversial results due to the sample size or variations in the antioxidants prescribed or the outcomes evaluated in them.…”
Section: Introductionmentioning
confidence: 99%